This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
BSN medical
BSN medical was a German medical technology company active in woundcare, compression, and orthopaedics that had been acquired by a major European private equity firm. In 2014, the E3 Life team joined the senior management team of BSN medical to strategically reposition the company from a stable, low-growth company into a high-innovation, high-growth enterprise.
The E3 Life team successfully implemented a commercial excellence program and completed 12 accretive acquisitions that inorganically expanded the portfolio, the technologies, and the geographic footprint of the company.
We structured the R&D process and organization, rapidly expanded the internal pipeline of the company, and bolstered BSN’s scientific, medical, and regulatory capabilities.
These measures resulted in a strengthened company and a substantial valuation uplift. BSN was successfully sold to a strategic acquirer in 2017 for an attractive investment return.